|
07.45
|
BREAKFAST
|
|
|
Hot topics in bone pharmacology
Chairs: Rod Flower (London, UK)/tbc |
|
08.30
|
Matt Gillespie (Melbourne, Australia): The LPR5/WNT signalling
pathway
|
|
09.10
|
Mark Nuttall (King of Prussia PA, USA): Drug discovery:
anabolics and current opportunities
|
|
09.40
|
Ed Nemeth (Toronto, Canada): Pharmacology of the calcium-sensing
receptor and drug development
|
|
10.20
|
COFFEE
|
| |
Bone anabolics: Parathyroid hormone
Chairs: Peter Ebeling (Oxford, UK)/Jonathan Reeve (Cambridge,
UK)
|
|
10.45
|
Gary Krishnan (Indianapolis IN, USA): Understanding the
basis for anabolic actions
|
|
11.15
|
Donato Agnusdei (Florence, Italy): Clinical results
|
|
11.45
|
Philippe Clezardin (Lyons, France): Mechanisms by which bisphosphonates
alter tumour behaviour in bone
|
|
|
New drugs: Strontium
|
|
12.15
|
Pierre Marie (Paris, France): Strontium and bone
|
|
12.45
|
LUNCH (12.45-13.30)
|
|
|
Nutriceuticals
Chairs: Steven Cummings (San Francisco CA, USA)/Richard
Eastell (Sheffield, UK)
|
|
13.30
|
Roman Mühlbauer (Berne, Switzerland): Plants and terpenoids
|
| |
Metalloproteinases |
|
14.10
|
Steve Krane (Boston MA, USA): Metalloproteinases and bone
|
|
|
|
|
14.50
|
TEA
|
| |
|
| |
Tissue engineering and gene therapy
Chairs: Zhanfeng Cui (Oxford, UK)/Jim Triffitt (Oxford,
UK)
|
|
15.20
|
Anthony Hollander (Bristol, UK): Cartilage engineering
|
|
16.00
|
Thomas Einhorn (Boston MA, USA): Bone engineering
|
|
|
|
|
16.40
|
Close
|
|
|
|
|
19.00
|
DINNER
|
